Article
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
2022-09-14
Abstract excerpt
<h4>Background</h4> Risk-assessment of endometrial cancer (EC) is based on clinicopathological factors and molecular subgroup. It is unclear whether adding hormone receptor expression, L1CAM expression or CTNNB1 status yields prognostic refinement. <h4>Methods</h4> Paraffin-embedded tumour samples of women with high-risk EC (HR-EC) from the PORTEC-3 trial (n=424), and a Dutch prospective clinical cohort called MST...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 239a8baa-ba43-5196-8d47-bf429cad0f32
- DOI
- 10.1101/2022.09.13.22279853
